D. Ozbasar Et Al. , "Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy," JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.36, no.1, pp.133-137, 2010
Ozbasar, D. Et Al. 2010. Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.36, no.1 , 133-137.
Ozbasar, D., Toros, U., Ozkaya, O., SEZİK, M., Uzun, H., Genc, H., ... Kaya, H.(2010). Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.36, no.1, 133-137.
Ozbasar, Demir Et Al. "Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy," JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.36, no.1, 133-137, 2010
Ozbasar, Demir Et Al. "Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy." JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.36, no.1, pp.133-137, 2010
Ozbasar, D. Et Al. (2010) . "Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy." JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.36, no.1, pp.133-137.
@article{article, author={Demir Ozbasar Et Al. }, title={Raloxifene decreases serum malondialdehyde and nitric oxide levels in postmenopausal women with end-stage renal disease under chronic hemodialysis therapy}, journal={JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH}, year=2010, pages={133-137} }